drugset / Trial / NCT02234882

Study on Pharmacokinetics

NCT02234882

Phase 1 Completed 50 enrolled ViiV Healthcare GlaxoSmithKline · collab
NaSingle-groupOpen-labelOther

Summary

The purpose of this study is to assess the effect of the coadministration of multiple doses of BMS-663068 on the systemic exposure of rosuvastatin.

Timeline

Start
2014-09-05
Primary completion
2014-10-31
Completion
2014-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Fostemsavir Other / unclassified
Subject Rosuvastatin Small molecule